Literature DB >> 16100153

The effects of short-term and long-term pulmonary rehabilitation on functional capacity, perceived dyspnea, and quality of life.

David Verrill1, Cole Barton, Will Beasley, W Michael Lippard.   

Abstract

STUDY
OBJECTIVES: The purposes of this study were as follows: (1) to determine whether physical performance, quality of life, and dyspnea with activities of daily living improved following both short-term and long-term pulmonary rehabilitation (PR) across multiple hospital outpatient programs; (2) to examine the differences in these parameters between men and women; and (3) to determine what relationships existed between the psychosocial parameters and the results of the 6-min walk (6MW) test performance across programs.
DESIGN: Non-experimental, prospective, and comparative.
SETTING: Seven outpatient hospital PR programs from urban and rural settings across North Carolina. PARTICIPANTS: Three hundred nine women and 281 men who were 20 to 93 years of age (mean [+/- SD] age, 66.7 +/- 11.1 years) with chronic lung disease.
INTERVENTIONS: All 6MW tests and health surveys were administered prior to and immediately following 12 and 24 weeks of supervised PR participation. Scores from the 6MW tests, the Ferrans and Powers quality of life index-pulmonary version III (QLI), the Medical Outcomes Study 36-item short form (SF-36), and the University of California at San Diego shortness of breath questionnaire (SOBQ) were compared at PR entry, at 12 weeks, and at 24 weeks for differences by gender with repeated-measures analysis of variance. The study entry and follow-up SF-36 physical and mental component summary scores, the QLI health/function and overall scores, and the SOBQ scores were also compared to the 6MW test scores with Pearson correlation coefficient analysis.
RESULTS: The mean summary scores on the SF-36 and the QLI increased after 12 weeks of PR (p < 0.05), and improvements were maintained by 24 weeks of PR participation (p < 0.05). Scores on the SOBQ improved after 12 weeks (p < 0.001) among the short-term participants, but not until after 24 weeks among the long-term participants (p = 0.009). The 6MW test performance improved after 12 weeks (p < 0.001) and again from 12 to 24 weeks (p = 0.002) in the long-term participants. No relevant correlational relationships were found between 6MW scores and the summary scores of the administered surveys (r = -0.43 to 0.36).
CONCLUSIONS: Physical performance, as measured by the 6MW test, continued to improve with up to 24 weeks of PR participation. Quality-of-life measures and the perception of dyspnea improved after 12 weeks of PR participation, with improvements maintained by 24 weeks of PR participation. It is recommended that PR patients participate in supervised PR for at least 24 weeks to gain and maintain optimal health benefits.

Entities:  

Mesh:

Year:  2005        PMID: 16100153     DOI: 10.1378/chest.128.2.673

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  19 in total

1.  Tai chi exercise for patients with chronic obstructive pulmonary disease: a pilot study.

Authors:  Gloria Y Yeh; David H Roberts; Peter M Wayne; Roger B Davis; Mary T Quilty; Russell S Phillips
Journal:  Respir Care       Date:  2010-11       Impact factor: 2.258

2.  Pulmonary complications in patients with chronic obstructive pulmonary disease following transthoracic esophagectomy.

Authors:  Wen-Jie Jiao; Tian-You Wang; Min Gong; Hao Pan; Yan-Bing Liu; Zhi-Hua Liu
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

3.  Chronic obstructive pulmonary disease in women.

Authors:  Louis Laviolette; Yves Lacasse; Mariève Doucet; Miriam Lacasse; Karine Marquis; Didier Saey; Pierre Leblanc; François Maltais
Journal:  Can Respir J       Date:  2007-03       Impact factor: 2.409

Review 4.  Optimizing pulmonary rehabilitation in chronic obstructive pulmonary disease--practical issues: a Canadian Thoracic Society Clinical Practice Guideline.

Authors:  Darcy D Marciniuk; Dina Brooks; Scott Butcher; Richard Debigare; Gail Dechman; Gordon Ford; Veronique Pepin; Darlene Reid; Andrew W Sheel; Micheal K Stickland; David C Todd; Shannon L Walker; Shawn D Aaron; Meyer Balter; Jean Bourbeau; Paul Hernandez; Francois Maltais; Denis E O'Donnell; Donna Bleakney; Brian Carlin; Roger Goldstein; Stella K Muthuri
Journal:  Can Respir J       Date:  2010 Jul-Aug       Impact factor: 2.409

5.  The minimal important difference of exercise tests in severe COPD.

Authors:  M A Puhan; D Chandra; Z Mosenifar; A Ries; B Make; N N Hansel; R A Wise; F Sciurba
Journal:  Eur Respir J       Date:  2010-08-06       Impact factor: 16.671

6.  Validation of a new questionnaire with generic and disease-specific qualities: the McGill COPD Quality of Life Questionnaire.

Authors:  Smita Pakhale; Sharon Wood-Dauphinee; Adriana Spahija; Jean-Paul Collet; Francois Maltais; Sarah Bernard; Marc Baltzan; Michel Rouleau; Jean Bourbeau
Journal:  Can Respir J       Date:  2012 Nov-Dec       Impact factor: 2.409

7.  Effects of 3-week outpatient pulmonary rehabilitation on exercise capacity, dyspnea, and quality of life in COPD.

Authors:  Andreas von Leupoldt; Erika Hahn; Karin Taube; Stephan Schubert-Heukeshoven; Helgo Magnussen; Bernhard Dahme
Journal:  Lung       Date:  2008-04-12       Impact factor: 2.584

8.  [The effect of one year outpatient pulmonary rehabilitation on patients with COPD].

Authors:  Ralf H Zwick; Otto C Burghuber; Natasa Dovjak; Sylvia Hartl; Wolfgang Kössler; Alfred Lichtenschopf; Rudolf Müller; Hartmut Zwick
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

9.  Effect of Virtual Reality-Based Rehabilitation on Physical Fitness in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Sebastian Rutkowski; Anna Rutkowska; Dariusz Jastrzębski; Henryk Racheniuk; Witold Pawełczyk; Jan Szczegielniak
Journal:  J Hum Kinet       Date:  2019-10-18       Impact factor: 2.193

Review 10.  Role of N-acetylcysteine in the management of COPD.

Authors:  Anna M Sadowska; J Verbraecken; K Darquennes; W A De Backer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.